| 摘要 |
Disclosed is the use of a water soluble, non-digestible saccharide for the manufacture of a composition for (i) improving the intestinal flora development of an infant after birth; and/or (ii) strengthening the immune system and/or prevention of immune system related disorders of the infant after birth, wherein said composition is for administration to a woman pregnant with the infant; and the use of a water soluble, non-digestible saccharide for the manufacture of a composition for preventing a disorder selected from the group consisting of allergy, eczema, asthma, rhinitis, hayfever, rhinoconjunctivitis, wheezing, intestinal infections, vaginal infections, respiratory infections, diarrhoea, constipation, cramps and intestinal inflammation in an infant after birth, wherein said composition is for administration to a woman pregnant with the infant. Said non-digestible saccharide may be selected from the group consisting of transgalactooligosaccharides, galactooligosaccharides, lacto-N-tetraose (LNT), lacto-N-neotetraose (neoLNT), fucosyl-Iactose, fucosylated LNT and fucosylated neo-LNT, and alpha-galactooligosaccharide. |
